Search for Clinical Trial Results

Sponsored By

Leishmaniasis - 86 Studies Found

Status Study
Completed Study Name: Use of Sodium Stibogluconate as a Treatment for Leishmaniasis
Condition: Leishmaniasis
Date: 2008-04-08
Interventions: Drug: Sodium Stibogluconate (SSG) 100 mg/ml/vial. Treatment for laboratory-confirmed leishmaniasis with
Completed Study Name: Sodium Stibogluconate Treatment of Leishmaniasis
Condition: Leishmaniasis
Date: 2008-04-15
Interventions: Drug: Sodium Stibogluconate (SSG) 100 mg/ml/vial. Treatment for laboratory-confirmed leishmaniasis with
Not yet recruiting Study Name: Predicting Visceral Leishmaniasis in HIV Infected Patients
Condition: Leishmaniasis, Visceral
Date: 2017-01-05
Interventions: Other: No intervention No intervention
Recruiting Study Name: The Association of Miltefosine and Pentoxifylline to Treat Mucosal Leishmaniasis: A Clinical Trial in Brazil
Condition: Leishmaniasis
Date: 2015-08-19
Interventions:
  • Drug: Meglumine antimoniate 20
Completed Study Name: Topical Treatment of Cutaneous Leishmaniasis With WR 279,396: A Phase 2 Study in the Old World
Condition: Cutaneous Leishmaniasis
Date: 2008-06-20
Interventions:
  • Drug: WR 279,396 A topical cre
Completed Study Name: Efficacy of Topical Liposomal Form of Drugs in Cutaneous Leishmaniasis
Condition: Cutaneous Leishmaniasis
Date: 2010-01-13
Interventions:
  • Drug: Liposomal meglumine antimoniate (Glucantime)

Completed Study Name: Phase 3 Study to Evaluate WR 279,396 vs. Paromomycin Alone to Treat Cutaneous Leishmaniasis (in Tunisia)
Condition: Cutaneous Leishmaniasis
Date: 2008-01-21
Interventions:
  • Drug: WR 279,396 topical cream

Completed Study Name: Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine Antimoniate and Allopurinol
Condition: Leishmaniasis, Cutaneous
Date: 2007-05-29
Interventions:
  • Drug: meglumine antimoniate, allopurinol

Completed Study Name: Amphotericin B Treatment in Visceral Leishmaniasis
Condition: Visceral Leishmaniasis
Date: 2006-04-03
Interventions: Drug: Amphotericin B deoxycholate given as daily administration
Recruiting Study Name: Dedicated QT Study in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis
Condition: Mucocutaneous Leishmaniasis
Date: 2015-04-22
Interventions: Drug: Miltefosine
Next >>>